H.R. 5074 · 118th Congress · House

Kidney PATIENT Act of 2023

Active· Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.
Introduced
Jul 28, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 or the Kidney PATIENT Act of 2023

This bill delays a change to the payment methodology under Medicare for oral drugs that are used to treat end-stage renal disease (ESRD).

Under current regulations, beginning January 1, 2025, the Centers for Medicare & Medicaid Services will incorporate payments for oral-only ESRD drugs into the ESRD prospective payment system rather than issuing separate payments to ESRD facilities. The bill delays implementation of this policy until January 1, 2033, or until an approved intravenous drug is available, whichever is earlier.

Action Timeline

14
  1. JUN 11, 2024•Committee

    Reported (Amended) by the Committee on Ways and Means

    H. Rept. 118-548, Part I.

    118Yea
    548Nay
    0NV
  2. JUN 11, 2024•Committee

    Reported (Amended) by the Committee on Ways and Means

    H. Rept. 118-548, Part I.

    118Yea
    548Nay
    0NV
  3. MAR 20, 2024•Committee

    Committee Consideration and Mark-up Session Held

  4. MAR 20, 2024•Committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 37 - 10.

    37Yea
    10Nay
    0NV
  5. MAR 12, 2024•Committee

    Subcommittee Consideration and Mark-up Session Held

  6. MAR 12, 2024•Committee

    Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 16 - 10.

    16Yea
    10Nay
    0NV
  7. MAR 06, 2024•Committee

    Committee Consideration and Mark-up Session Held

  8. MAR 06, 2024•Committee

    Committee Consideration and Mark-up Session Held

  9. MAR 06, 2024•Committee

    Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 1.

    41Yea
    1Nay
    0NV
  10. AUG 04, 2023•Committee

    Referred to the Subcommittee on Health.

  11. JUL 28, 2023•IntroReferral

    Introduced in House

  12. JUL 28, 2023•IntroReferral

    Introduced in House

  13. JUL 28, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  14. JUL 28, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

8

Ways and Means Committee

hswm00

Referred: Jun 11, 2024

Active

Energy and Commerce Committee

hsif00

Referred: Mar 20, 2024

Active

Health Subcommittee

hsif14

Referred: Mar 12, 2024

Active

Health Subcommittee

hsif14

Referred: Mar 12, 2024

Active

Ways and Means Committee

hswm00

Referred: Mar 6, 2024

Active

Health Subcommittee

hsif14

Referred: Aug 4, 2023

Active

Ways and Means Committee

hswm00

Referred: Jul 28, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Jul 28, 2023

Active